|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
(Print or Type Responses)
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Options to purchase Series B convertible preferred stock(1) | 05/01/2012 | 05/01/2015 | Common Stock | 20,000,000 | $2.5 | I | By Wealth Preservation, LLC |
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| ORING MARTIN B 7582 HAWKS LANDING DRIVE WEST PALM BEACH, FL 33412 |
X | |||
| /s/ Martin Oring | 10/18/2012 | |
| ** Signature of Reporting Person |
Date
|
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The options were originally granted on May 1, 2012 as options to purchase up to 25,000 shares of common stock of Eos Petro, Inc. ("Eos") for Mr. Oring's services as a non-employee director of Eos. The options were subsequently converted into options to purchase up to 25,000 shares of Series B convertible preferred stock of Cellteck, Inc. ("Cellteck") on October 12, 2012 in connection with the merger of Cellteck and Eos. Each share of Series B convertible preferred stock automatically converts into 800 shares of common stock of Cellteck upon the filing of a certain amendment to Cellteck's Articles of Incorporation. The options vested immediately on the grant date. |